Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard E Chaisson

Showing results (161-170 of 241) with videos related to

Pageof 25
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2011
Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosisCeline R Gounder, Tendesayi Kufa, Nikolas I Wada, et al.
Arthritis and Rheumatism|January 13, 2012
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitisElizabeth C Hsia, Neil Schluger, John J Cush, et al.
The New England Journal of Medicine|January 24, 2014
A trial of mass isoniazid preventive therapy for tuberculosis controlGavin J Churchyard, Katherine L Fielding, James J Lewis, et al.
Plos One|January 9, 2009
Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adultsDavid W Dowdy, Maria C Lourenço, Solange C Cavalcante, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIVMahmoud Tareq Abdelwahab, Rory Leisegang, Kelly E Dooley, et al.
American Journal of Respiratory and Critical Care Medicine|August 13, 2004
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
Proceedings of the American Thoracic Society|June 10, 2011
HIV-associated lung infections and complications in the era of combination antiretroviral therapyKristina Crothers, Bruce W Thompson, Kathryn Burkhardt, et al.
The Lancet. Infectious Diseases|August 20, 2013
Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trialBetina Durovni, Valeria Saraceni, Lawrence H Moulton, et al.
BMC Health Services Research|September 9, 2024
Improving access to tuberculosis preventive treatment for children in Ethiopia: designing a home-based contact management intervention for the CHIP-TB trial through formative researchNicole Salazar-Austin, Alanna J Bergman, Christiaan Mulder, et al.
JAMA|June 9, 2005
Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment studyAlison D Grant, Salome Charalambous, Katherine L Fielding, et al.
Pageof 25

Showing results (161-170 of 241) with videos related to

Sort By:
Pageof 25
Journal of Acquired Immune Deficiency Syndromes (1999)|July 19, 2011
Diagnostic accuracy of a urine lipoarabinomannan enzyme-linked immunosorbent assay for screening ambulatory HIV-infected persons for tuberculosisCeline R Gounder, Tendesayi Kufa, Nikolas I Wada, et al.
Arthritis and Rheumatism|January 13, 2012
Interferon-γ release assay versus tuberculin skin test prior to treatment with golimumab, a human anti-tumor necrosis factor antibody, in patients with rheumatoid arthritis, psoriatic arthritis, or ankylosing spondylitisElizabeth C Hsia, Neil Schluger, John J Cush, et al.
The New England Journal of Medicine|January 24, 2014
A trial of mass isoniazid preventive therapy for tuberculosis controlGavin J Churchyard, Katherine L Fielding, James J Lewis, et al.
Plos One|January 9, 2009
Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adultsDavid W Dowdy, Maria C Lourenço, Solange C Cavalcante, et al.
Antimicrobial Agents and Chemotherapy|December 18, 2019
Population Pharmacokinetics of Isoniazid, Pyrazinamide, and Ethambutol in Pregnant South African Women with Tuberculosis and HIVMahmoud Tareq Abdelwahab, Rory Leisegang, Kelly E Dooley, et al.
American Journal of Respiratory and Critical Care Medicine|August 13, 2004
Moxifloxacin-containing regimens of reduced duration produce a stable cure in murine tuberculosisEric L Nuermberger, Tetsuyuki Yoshimatsu, Sandeep Tyagi, et al.
Proceedings of the American Thoracic Society|June 10, 2011
HIV-associated lung infections and complications in the era of combination antiretroviral therapyKristina Crothers, Bruce W Thompson, Kathryn Burkhardt, et al.
The Lancet. Infectious Diseases|August 20, 2013
Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trialBetina Durovni, Valeria Saraceni, Lawrence H Moulton, et al.
BMC Health Services Research|September 9, 2024
Improving access to tuberculosis preventive treatment for children in Ethiopia: designing a home-based contact management intervention for the CHIP-TB trial through formative researchNicole Salazar-Austin, Alanna J Bergman, Christiaan Mulder, et al.
JAMA|June 9, 2005
Effect of routine isoniazid preventive therapy on tuberculosis incidence among HIV-infected men in South Africa: a novel randomized incremental recruitment studyAlison D Grant, Salome Charalambous, Katherine L Fielding, et al.
Pageof 25